AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rezolute, Inc. Director's Dealing 2017

Mar 15, 2017

32362_dirs_2017-03-15_b30c1602-7e82-4363-9e3d-7f1d06b1a723.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2017-03-08

Reporting Person: Welch David F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-08	Common Stock	P	5000	$0.98	Acquired	1801415	Indirect
2017-03-09	Common Stock	P	5000	$0.95	Acquired	1806415	Indirect
2017-03-10	Common Stock	P	5000	$0.95	Acquired	1811415	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	28100	Indirect
Common Stock	15000	Direct

Footnotes

F1: The Reporting Person is General Partner of Welch Group, LP and has voting and dispositive power of the shares of the Issuer's common stock owned by Welch Group, LP.

F2: The Reporting Person is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock owned by LRFA, LLC.